CYTOVANCE Trademark

Trademark Overview

On Tuesday, July 29, 2003, a trademark application was filed for CYTOVANCE with the United States Patent and Trademark Office. The USPTO has given the CYTOVANCE trademark a serial number of 78280279. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 30, 2025. This trademark is owned by Cytovance, Inc.. The CYTOVANCE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

CUSTOM MANUFACTURE OF PHARMACEUTICALS
cytovance

General Information

Serial Number78280279
Word MarkCYTOVANCE
Filing DateTuesday, July 29, 2003
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 30, 2025
Registration Number2891313
Registration DateTuesday, October 5, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 13, 2004

Trademark Statements

Goods and ServicesCUSTOM MANUFACTURE OF PHARMACEUTICALS

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, August 11, 2003
Primary Code040
First Use Anywhere DateWednesday, January 1, 2003
First Use In Commerce DateWednesday, January 1, 2003

Trademark Owner History

Party NameCYTOVANCE BIOLOGICS, L.L.C.
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressOKLAHOMA CITY, OK 73104
Party NameCYTOVANCE BIOLOGICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressOKLAHOMA CITY, OK 73104
Party NameCytovance, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameCytovance, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameCytovance, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Tuesday, February 17, 2004NON-FINAL ACTION E-MAILED
Tuesday, February 17, 2004ASSIGNED TO EXAMINER
Tuesday, October 5, 2004REGISTERED-PRINCIPAL REGISTER
Thursday, February 3, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 29, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 31, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 31, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 26, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2004NOTICE OF PUBLICATION
Tuesday, July 13, 2004PUBLISHED FOR OPPOSITION
Friday, January 21, 2011TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 26, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 3, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 18, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 5, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, October 7, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, January 30, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 30, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, January 30, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 6, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 6, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, April 18, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, April 18, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, April 18, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, October 14, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, January 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

cytovance pharmaceuticals manufacture custom